Literature DB >> 35532797

A machine learning approach applied to gynecological ultrasound to predict progression-free survival in ovarian cancer patients.

Francesca Arezzo1, Gennaro Cormio2, Daniele La Forgia3, Carla Mariaflavia Santarsiero2, Michele Mongelli2, Claudio Lombardi2, Gerardo Cazzato4, Ettore Cicinelli2, Vera Loizzi5.   

Abstract

In a growing number of social and clinical scenarios, machine learning (ML) is emerging as a promising tool for implementing complex multi-parametric decision-making algorithms. Regarding ovarian cancer (OC), despite the standardization of features that can support the discrimination of ovarian masses into benign and malignant, there is a lack of accurate predictive modeling based on ultrasound (US) examination for progression-free survival (PFS). This retrospective observational study analyzed patients with epithelial ovarian cancer (EOC) who were followed in a tertiary center from 2018 to 2019. Demographic features, clinical characteristics, information about the surgery and post-surgery histopathology were collected. Additionally, we recorded data about US examinations according to the International Ovarian Tumor Analysis (IOTA) classification. Our study aimed to realize a tool to predict 12 month PFS in patients with OC based on a ML algorithm applied to gynecological ultrasound assessment. Proper feature selection was used to determine an attribute core set. Three different machine learning algorithms, namely Logistic Regression (LR), Random Forest (RFF), and K-nearest neighbors (KNN), were then trained and validated with five-fold cross-validation to predict 12 month PFS. Our analysis included n. 64 patients and 12 month PFS was achieved by 46/64 patients (71.9%). The attribute core set used to train machine learning algorithms included age, menopause, CA-125 value, histotype, FIGO stage and US characteristics, such as major lesion diameter, side, echogenicity, color score, major solid component diameter, presence of carcinosis. RFF showed the best performance (accuracy 93.7%, precision 90%, recall 90%, area under receiver operating characteristic curve (AUROC) 0.92). We developed an accurate ML model to predict 12 month PFS.
© 2022. The Author(s).

Entities:  

Keywords:  Gynecological ultrasound; Machine learning; Ovarian cancer; Progression-free survival

Year:  2022        PMID: 35532797     DOI: 10.1007/s00404-022-06578-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.493


  38 in total

1.  Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules.

Authors:  Jacques S Abramowicz; Dirk Timmerman
Journal:  Am J Obstet Gynecol       Date:  2017-07-20       Impact factor: 8.661

2.  Comparison of International Ovarian Tumor Analysis Simple Rules to Society of Radiologists in Ultrasound Guidelines for Detection of Malignancy in Adnexal Cysts.

Authors:  Krupa K Patel-Lippmann; Elizabeth A Sadowski; Jessica B Robbins; Viktoriya Paroder; Lisa Barroilhet; Elizabeth Maddox; Timothy McMahon; Emmanuel Sampene; Ashish P Wasnik; Alexander D Blaty; Katherine E Maturen
Journal:  AJR Am J Roentgenol       Date:  2019-11-26       Impact factor: 3.959

Review 3.  Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature.

Authors:  Vera Loizzi; Luca Leone; Anna Camporeale; Leonardo Resta; Luigi Selvaggi; Ettore Cicinelli; Gennaro Cormio
Journal:  Oncology       Date:  2016-08-03       Impact factor: 2.935

4.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

5.  Neoadjuvant chemotherapy in advanced ovarian cancer: a case-control study.

Authors:  V Loizzi; G Cormio; L Resta; C A Rossi; A R Di Gilio; A Cuccovillo; L Selvaggi
Journal:  Int J Gynecol Cancer       Date:  2005 Mar-Apr       Impact factor: 3.437

6.  Spleen involvement in women with ovarian cancer.

Authors:  G Cormio; V Loizzi; C Carriero; G Putignano; L Selvaggi
Journal:  Eur J Gynaecol Oncol       Date:  2009       Impact factor: 0.196

7.  Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.

Authors:  Dirk Timmerman; Ben Van Calster; Antonia Testa; Luca Savelli; Daniela Fischerova; Wouter Froyman; Laure Wynants; Caroline Van Holsbeke; Elisabeth Epstein; Dorella Franchi; Jeroen Kaijser; Artur Czekierdowski; Stefano Guerriero; Robert Fruscio; Francesco P G Leone; Alberto Rossi; Chiara Landolfo; Ignace Vergote; Tom Bourne; Lil Valentin
Journal:  Am J Obstet Gynecol       Date:  2016-01-19       Impact factor: 8.661

8.  Borderline epithelial tumors of the ovary: Experience of 55 patients.

Authors:  Vera Loizzi; Luigi Selvaggi; Luca Leone; Donatella Latorre; Doriana Scardigno; Francescapaola Magazzino; Gennaro Cormio
Journal:  Oncol Lett       Date:  2014-12-02       Impact factor: 2.967

9.  Early detection of ovarian cancer.

Authors:  Rosemarie Forstner
Journal:  Eur Radiol       Date:  2020-05-28       Impact factor: 5.315

Review 10.  The Role of Ultrasound Guided Sampling Procedures in the Diagnosis of Pelvic Masses: A Narrative Review of the Literature.

Authors:  Francesca Arezzo; Vera Loizzi; Daniele La Forgia; Adam Abdulwakil Kawosha; Erica Silvestris; Viviana Cataldo; Claudio Lombardi; Gerardo Cazzato; Giuseppe Ingravallo; Leonardo Resta; Gennaro Cormio
Journal:  Diagnostics (Basel)       Date:  2021-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.